PAOG Financial Report Compliance Expected Soon Following Recent CBD Biotech Acquisitions

Sandusky, Ohio–(Newsfile Corp. – August 21, 2020) – PAO Group, Inc. (OTC Pink: PAOG) confirmed today that the company expects to soon have its public disclosures in compliance with OTC Markets “Current Information” reporting standard. The efforts underway are expected to see the company back in compliance no later than by the end of this month.

PAOG recently executed two acquisitions as part of an overall business revitalization strategy bringing the company into the CBD biopharmaceutical sector. The revitalization strategy includes updating the company’s financial statements to make the company compliant with the OTC Markets’ “Current Information” reporting standard.

www.paogroupinc.com.

Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

CONTACT INFORMATION

Contact Us:
Jim DiPrima
888-272-6472
info@pao.group

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/62284